Clinical trial
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
NCT01789320 is registered in ClinicalTrials.gov with Clearside Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
- Lead sponsor
- Clearside Biomedical, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- March 31, 2015
- Enrollment
- 11 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
intermediate uveitis, noninfectious uveitis, panuveitis, posterior uveitis, uveitis